Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Press Release

Document Details

Form
DEFA14A
Filing Date
Apr 9, 2026
Document Date
Apr 9, 2026
Form Description
Additional proxy soliciting materials - definitive
Filing Group
Proxy Filings
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/

Filing Formats

View HTML
Download PDF
Download DOC